Background/Aim: The availability of sensitive thyrotropin (TSH) assays decreased the diagnostic value of thyrotropin-releasing hormone stimulation tests (TRH-ST) in subclinical hypothyroidism. In this study we aimed to evaluate the relation between basal and stimulated serum TSH levels on TRH-ST and to determine the prevalence of patients with normal basal serum TSH and exaggerated TSH responses. Methods: 179 patients (117 girls, 123 pubertal) with a median age of 12 (2.7–21.4) years who presented with goiter were enrolled and evaluated for their pubertal stage, height, thyroid autoimmunity, ultrasonography, thyroid function, and TRH-ST. Serum TSH concentrations were determined by sensitive assays. At TRH-ST, a peak serum TSH level >25 mIU/l was considered as an exaggerated response. Results: 30 (17%) patients had an exaggerated TSH response. In patients with serum TSH levels between 2 and 4.68 mIU/l (upper half the normal range), an exaggerated TSH response was observed in 19.5%. A positive correlation between basal and TRH-stimulated TSH levels was determined (r = 0.536, p < 0.01). In patients with an exaggerated TSH response, 23 had normal (discordant) and 7 had high basal TSH levels (concordant). The mean basal serum TSH level was lower in the discordant group compared to the concordant group (p < 0.01). Conclusion: Basal serum TSH levels might not be sufficient for diagnosing subclinical hypothyroidism. Stimulated TSH levels on TRH-ST are valuable, especially when serum TSH concentrations are in the upper half of the normal range.

Keywords:
Thyrotropin, Thyrotropin-releasing hormone, TSH stimulation test, Goiter
1.
Evered DC, Ormston BJ, Smith PA, Hall R, Bird T: Grades of hypothyroidism. Br Med J 1973;17:657–662.
2.
Kabadi UM: Subclinical hypothyroidism. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 1993;153:957–961.
3.
Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E, Aral Y: The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J Endocrinol Invest 2004;27:897–903.
4.
Hak AE, Pols H, Visser TJ, Drexhage HA, Hofman A, Witteman JC: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270–278.
5.
Surks MI, Ortiz E, Daniels GH, et al: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228–238.
6.
Gharib H, Tuttle RM, Baskin HC, Fish LH, Singer PA, McDermott MT: Consensus Statement: Subclinical thyroid dysfunction: a joint statement on management from the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005;90:581–585.
7.
Cetinkaya E, Aslan A, Vidinlisan S, Ocal G: Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int 2003;45:534–537.
8.
DeGroot LJ: Endocrinology; in DeGroot LJ (ed): Endocrinology. Toronto, Saunders, 1989, vol 1.
9.
Grasso L, Bartalena L, Mammoli C, Martino E, Kessler AC, Pinchera A: Serum TSH measurements by a sensitive enzyme immunoassay discriminate euthyroid from hyperthyroid subjects and avoid the need for TRH test during suppressive therapy with L-thyroxine. Clin Biochem 1987;20:197–200.
10.
Oppenheimer JH: Role of plasma proteins in the binding, distribution and metabolism of the thyroid hormones. N Engl J Med 1968;278:1153–1162.
11.
Westerhuis LW, Venekamp WJ: Falsely high serum free thyroxine concentration measured with Amerlite-MAB FT4. Clin Chem 1995;41:633–634.
12.
Levinson S: The nature of heterophilic antibodies and their role in immunoassay interference. J Clin Immunoassay 1992;15:108–115.
13.
Calam R: Specimen processsing separator gels: an update. J Clin Immunoassay 1988;11:86–90.
14.
Keefer J: Preanalytic considerations in testing thyroid function. Clin Chem 1996;42:125–134.
15.
Czarnocka B, Ruf J, Ferrand M: Interaction of highly purified thyroid peroxidase with antimicrosomal antibodies in autoimmune thyroid diseases. J Endocrinol Invest 1986;9:135–138.
16.
Dattani MT: Tests in paediatric endocrinology and normal values; in Brook CG, Hindmarsh PC (eds): Clinical Pediatric Endocrinology. Malden, Blackwell Science, 2001, pp 467–490.
17.
Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC: Volumetric analysis of thyroid lobes by real-time ultrasound (in German). Dtsch Med Wochenschr 1981;106:1338–1340.
18.
Zimmermann MB, Molinari L, Spehl M, et al: Toward a consensus on reference values for thyroid volume in iodine-replete schoolchildren: results of a workshop on inter-observer and inter-equipment variation in sonographic measurement of thyroid volume. Eur J Endocrinol 2001;144:213–220.
19.
Klee G, Hay I: Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility. J Clin Endocrinol Metab 1987;64:461–471.
20.
Kraus RP, Phoenix E, Edmonds MW, Nicholson IR, Chandarana PC, Tokmakejian S: Exaggerated TSH responses to TRH in depressed patients with normal baseline TSH. J Clin Psychiatry 1997;58:266–270.
21.
Duntas L, Grab BM, Dominguez-Munoz JE, Nelson DK, Loos U, Keck FS: Evaluation of thyrotropin secretion before and after TRH by third-generation chemiluminescent assay. Assessment of subclinical hyperthyroidism. Horm Metab Res 1993;25:430–433.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.